PHARMA / AI / FUTURIST

EXECUTIVE DECISION BRIEF · U.S. PHARMA DIGITAL LEADERS

AI is changing how patients and HCPs discover, evaluate, and act on health information.Turn that shift into one governed 90-day pilot.

Start with one high-value journey, establish its evidence and discovery baseline, design the right human handoffs, and earn the decision to scale through measured results.

See the 90-day decision pathTake the 2-minute readiness check
AudienceU.S. pharma digital leaders
PurposeExecutive alignment and pilot decisions
MethodEvidence before prediction
BoundaryNot medical or regulatory guidance
01

Why now

The shift is already measurable.

Three current signals make this an operating decision—not a distant prediction.

01>80%

of physicians report using AI professionally

The HCP information environment is already changing; the governed source layer must keep pace.

American Medical Association
02Measurable

AI search is a distinct discovery surface

Google is testing dedicated generative-AI visibility reports. Teams can begin measuring presence while keeping strong search fundamentals.

Google Search CentralGoogle Search Central
02

The executive response

Turn the shift into a 90-day decision.

Start with one bounded journey, make ownership explicit, and earn the right to scale.

01 · DAYS 0–30

Choose and baseline

Select one journey. Document current discovery, content sources, handoffs, risks, owners, and success measures.

Journey baseline + accountable team
02 · DAYS 31–60

Design the governed pilot

Define context of use, approved knowledge, audience rules, consent, escalation, interfaces, and evaluation.

Pilot brief + governance contract
03 · DAYS 61–90

Test and decide

Measure discovery and journey quality, document failures, and make an evidence-based scale, revise, or stop decision.

Executive decision + next investment
Decision outputOne pilot, six explicit owners, and a documented next-investment decision.
Discuss a 90-day pilot
03

What must change

Six capabilities move together.

This is a cross-functional operating-model change—not a website redesign owned by Marketing alone.

01

Content & evidence

Future-ready behavior

Expert-led, non-commodity knowledge modules with provenance, context, reuse rules, and accountable owners.

Can we update one approved fact once and propagate it safely across every experience?
02

Experience & services

Future-ready behavior

Connected audience journeys that move from information to appropriate support and human action.

Where should a digital journey stop, hand off, or escalate to a qualified human?
03

Data & consent

Future-ready behavior

Explicit value exchange, first-party relationships, and governed event data by design.

Can a person understand what data is used, why it is useful, and how to change their choice?
04

AI discoverability

Future-ready behavior

Strong search foundations plus entity clarity, structured evidence, citation readiness, and measured AI visibility.

Would an answer system know which information is current, authoritative, and appropriate—without relying on unsupported GEO hacks?
05

Regulatory governance

Future-ready behavior

Risk-based controls tied to context of use, reusable approvals, evaluation, monitoring, and lifecycle management.

Can governance move at the speed of modular content without reducing rigor?
06

Platform architecture

Future-ready behavior

Shared services and governed interfaces for identity, content, evidence, consent, safety, analytics, and bounded action.

Which shared capabilities are enterprise infrastructure, and who is accountable for them?
04

Applied market signal

Connected services are already changing the role of the site.

Named market example

LillyDirect connects branded information to direct digital services.

The significance is the visible move from isolated pages toward connected information, access, and support services.

Eli Lilly and Company
What this briefing does

Separates evidence, market examples, and future scenario.

It does not present a client case, maturity benchmark, medical recommendation, or proof of established pharma adoption.

05

Two-minute readiness check

Make the first gaps visible.

Rate one practical statement for each capability before committing to the complete working-session assessment.

0 of 6 answered · about 2 minutes
01
Content & evidenceCore facts and approved claims have clear owners and source provenance.
02
Experience & servicesPatient and HCP journeys are designed across sites and channels, not one page at a time.
03
Data & consentData collection is tied to a documented customer benefit and business purpose.
04
AI discoverabilityKey entities, evidence, audience context, and update dates are clear in content and structured data.
05
Regulatory governanceMLR decisions can be traced to reusable content modules and their approved context.
06
Platform architectureContent, evidence, consent, safety, and analytics services have documented interfaces.

Author and strategist

Stephen Sweeney

Stephen Sweeney is a digital leader with more than 20 years of experience transforming web ecosystems. He writes about how AI-mediated discovery, governance, and digital operating models are reshaping pharmaceutical websites. Views expressed are his own.

About StephenStart a conversation

The leadership question

Are we improving pages, or preparing the organization for a new digital operating model?

Use the full briefing to align the room, then use the readiness profile to choose one bounded journey.

Discuss a governed pilot